Exact Mass: 364.00704240000005
Exact Mass Matches: 364.00704240000005
Found 134 metabolites which its exact mass value is equals to given mass value 364.00704240000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6-Thioinosine-5'-monophosphate
C10H13N4O7PS (364.02425580000005)
6-Thioinosine-5-monophosphate is a metabolite of mercaptopurine. Mercaptopurine (also called 6-mercaptopurine, 6-MP or its brand name Purinethol) is an immunosuppressive drug. It is a thiopurine. (Wikipedia)
Xanthylic acid
Xanthylic acid, also known as xmp or (9-D-ribosylxanthine)-5-phosphate, is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Xanthylic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Xanthylic acid can be found in a number of food items such as common grape, black-eyed pea, java plum, and wild rice, which makes xanthylic acid a potential biomarker for the consumption of these food products. Xanthylic acid exists in all living species, ranging from bacteria to humans. In humans, xanthylic acid is involved in several metabolic pathways, some of which include azathioprine action pathway, glutamate metabolism, mercaptopurine action pathway, and purine metabolism. Xanthylic acid is also involved in several metabolic disorders, some of which include purine nucleoside phosphorylase deficiency, succinic semialdehyde dehydrogenase deficiency, xanthine dehydrogenase deficiency (xanthinuria), and molybdenum cofactor deficiency. Xanthosine monophosphate is an intermediate in purine metabolism. It is a ribonucleoside monophosphate. It is formed from IMP via the action of IMP dehydrogenase, and it forms GMP via the action of GMP synthaseand is) also, XMP can be released from XTP by enzyme deoxyribonucleoside triphosphate pyrophosphohydrolase containing (d)XTPase activity . Xanthylic acid is an important metabolic intermediate in the Purine Metabolism, and is a product or substrate of the enzymes Inosine monophosphate dehydrogenase (EC 1.1.1.205), Hypoxanthine phosphoribosyltransferase (EC 2.4.2.8), Xanthine phosphoribosyltransferase (EC 2.4.2.22), 5-Ribonucleotide phosphohydrolase (EC 3.1.3.5), Ap4A hydrolase (EC 3.6.1.17), Nucleoside-triphosphate diphosphatase (EC 3.6.1.19), Phosphoribosylamine-glycine ligase (EC 6.3.4.1), and glutamine amidotransferase (EC 6.3.5.2). (KEGG) Xanthylic acid can also be used in quantitative measurements of the Inosine monophosphate dehydrogenase enzyme activities in purine metabolism. This measurement is important for optimal thiopurine therapy for children with acute lymphoblastic leukaemia (ALL). (PMID: 16725387). Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Tetrachlorobisphenol A
CONFIDENCE standard compound; INTERNAL_ID 547; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5355; ORIGINAL_PRECURSOR_SCAN_NO 5350 CONFIDENCE standard compound; INTERNAL_ID 547; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5349; ORIGINAL_PRECURSOR_SCAN_NO 5347 CONFIDENCE standard compound; INTERNAL_ID 547; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5353; ORIGINAL_PRECURSOR_SCAN_NO 5351 CONFIDENCE standard compound; INTERNAL_ID 547; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5359; ORIGINAL_PRECURSOR_SCAN_NO 5357 CONFIDENCE standard compound; INTERNAL_ID 547; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5328; ORIGINAL_PRECURSOR_SCAN_NO 5327
Fertilysin
C12H20Cl4N2O2 (364.02788200000003)
Win 18446 is an orally active testes-specific enzyme ALDH1a2 inhibitor, with an IC50 of 0.3 μM. Win 18446 reversibly inhibits spermatogenesis in many species and inhibits Retinoic acid (HY-14649) biosynthesis from Retinol (HY-B1342) within the testes[1][2].
5'-xanthylate(2-)
5-xanthylate(2-) is also known as 5-Xanthylate dianion or XMP. 5-xanthylate(2-) is considered to be slightly soluble (in water) and acidic
Biochanin a 7-sulfate
C16H12O8S (364.02528720000004)
Fertilysin
C12H20Cl4N2O2 (364.02788200000003)
Win 18446 is an orally active testes-specific enzyme ALDH1a2 inhibitor, with an IC50 of 0.3 μM. Win 18446 reversibly inhibits spermatogenesis in many species and inhibits Retinoic acid (HY-14649) biosynthesis from Retinol (HY-B1342) within the testes[1][2].
Indacrinone
D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
o-(pentafluorobenzyloxycarbonyl)-benzoyl chloride
C15H6ClF5O3 (363.99256160000004)
o-(pentafluorobenzyloxycarbonyl)benzoyl chloride
C15H6ClF5O3 (363.99256160000004)
thioinosine monophosphate
C10H13N4O7PS (364.02425580000005)
6-Bromo-1-methoxy-1,8-dihydroaplysinopsin
C15H17BrN4O2 (364.05348019999997)
Perfluoroheptanoic acid
CONFIDENCE standard compound; INTERNAL_ID 5947 CONFIDENCE standard compound; INTERNAL_ID 2410 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2716
((2R,3R,4S,5R)-5-(2,6-dioxo-1,2,3,6-tetrahydropurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl)methyl hydrogen sulfate
2-chloro-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|3-Dechlor-lecideoidin|3-Dechlorolecideoidin|dechlorolecideoidin
2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1,3-dihydroisobenzofuran-5-yl)-benzoic acid methyl ester
N-Methyl-2-[4-(3-aminopropoxy)-3,5-dibromophenyl]ethylamine
Thioinosinic acid
C10H13N4O7PS (364.02425580000005)
[Raw Data] CB244_Thioinosinic-acid_pos_50eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_40eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_30eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_20eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_10eV_CB000084.txt
Benzeneethanol, 2,4-dichloro-b-[(2,4-dichlorophenyl)methoxy]-
Gly-Phe4Cl-OH
C16H13ClN2O6 (364.04621080000004)
Phe4Cl-Gly-OH
C16H13ClN2O6 (364.04621080000004)
bis(triethylphosphine)nickel(ii) chloride
C12H30Cl2NiP2 (364.05531699999995)
methyl 5-chloro-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridine-3-carboxylate
C16H13ClN2O4S (364.0284528000001)
Benzenesulfonic acid,4-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-3-methyl-, sodium salt (1:1)
C17H13N2NaO4S (364.0493698000001)
5,6-Dichloro-1-ethyl-2-methyl-3-(3-sulfobutyl)benzimidazolium inner salt
C14H18Cl2N2O3S (364.0415138000001)
Suclofenide
C16H13ClN2O4S (364.0284528000001)
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
4-[(3,4-dichlorophenyl)methyl]-2,3-dihydro-1H-quinoxaline
C15H16Cl4N2 (364.00675359999997)
1H,1H,5H-OCTAFLUOROPENTYL TRIFLUOROMETHANESULFONATE
tert-butyl 5-bromo-3-(trifluoromethyl)indazole-1-carboxylate
C13H12BrF3N2O2 (364.00341879999996)
METHYL 3-(BENZOYLOXY)-5-BROMO-2-METHOXYBENZOATE
C16H13BrO5 (363.99463080000004)
Benzenemethanol,2,3,4,5,6-pentafluoro-a-(2,3,4,5,6-pentafluorophenyl)-
6-METHYL-5-(4-PHENYL-1,3-THIAZOL-2-YL)-2-(TRIFLUOROMETHYL)NICOTINIC ACID
ethyl 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate
C17H11ClF2N2O3 (364.04262300000005)
2-(3-Chloro-5-iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
5-(3-Iodo-1H-pyrrolo[2,3-b]pyridin-5-yl)-N,N-dimethyl-2-pyridinam ine
sodium,5-methyl-2-[(2Z)-2-(2-oxonaphthalen-1-ylidene)hydrazinyl]benzenesulfonate
C17H13N2NaO4S (364.0493698000001)
1H-PYRROLO[2,3-B]PYRIDINE, 3-BROMO-5-METHYL-1-[(4-METHYLPHENYL)SULFONYL]-
Thiazolidine, 2-(4-methylphenyl)-3-[(3-nitrophenyl)sulfonyl]- (9CI)
Thiazolidine, 2-(4-methylphenyl)-3-[(4-nitrophenyl)sulfonyl]- (9CI)
Sodium Diphenylphosphinobenzene-3-Sulfonate
C18H14NaO3PS (364.02989440000005)
1-(2-chloroethyl)-4-[3-(trifluoromethyl)phenyl]piperazine,dihydrochloride
1-(4-Amino-3,5-dibromophenyl)-2-(tert-butylamino)ethanol
2-bromomethyl-4-trifluoromethylbenzene boronic ester
5-(4-CYANO-BENZOYLAMINO)-2-ETHOXY-BENZENESULFONYL CHLORIDE
C16H13ClN2O4S (364.0284528000001)
4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide
C20H13ClN2OS (364.04370780000005)
5-(4-Bromophenyl)-2-phenylpyrazolo[1,5-a]pyrimidin-7-amine
5-chloro-4-(4-methylphenyl)sulfonyl-N-phenyl-2-thiazolamine
4-[1-[(3,4-Dichlorophenyl)methylamino]propylidene]-2-(2-furanyl)-5-oxazolone
C17H14Cl2N2O3 (364.03814339999997)
(5-Chloro-2-{[(3-Nitrobenzyl)amino]carbonyl}phenoxy)acetic Acid
C16H13ClN2O6 (364.04621080000004)
Indacrinone
D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
4-hydroxy-1,5,6-trimethyl-2,2-dioxo-N-phenylthieno[2,3-c]thiazine-3-carboxamide
5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[3-hydroxy-5-(6-oxo-1H-purin-9-yl)-4-sulfanyloxolan-2-yl]methyl dihydrogen phosphate
C10H13N4O7PS (364.02425580000005)
1-(4-Bromophenyl)-3-[2-(2-methoxyphenoxy)ethyl]urea
3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide
C15H13ClN4O3S (364.03968580000003)
N-(3-chlorophenyl)-2-[[2-(2-pyridinyl)-2,3-dihydro-1,3,4-thiadiazol-5-yl]thio]acetamide
4-(4-Bromophenyl)-2-(3,5-dimethyl-1-pyrazolyl)-4-oxobutanoic acid methyl ester
2-[[5-(2-fluoroanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-furanylmethyl)acetamide
C15H13FN4O2S2 (364.04639299999997)
2-(2-Bromophenyl)-5-[(2-chlorophenoxy)methyl]-1,3,4-oxadiazole
N,N-diethyl-2-[(3-thiophen-2-yl-7-isothiazolo[4,5-d]pyrimidinyl)thio]acetamide
N-[2-(4-bromo-2-methylphenoxy)-1-oxoethyl]-2-pyrazinecarbohydrazide
2-Chloro-5-[[[[(3-methoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid
C16H13ClN2O4S (364.0284528000001)
N-(2,6-dimethylphenyl)-1-methyl-2,2,4-trioxo-3-thieno[3,2-c]thiazinecarboxamide
1,5,6-trimethyl-2,2,4-trioxo-N-phenyl-3-thieno[2,3-c]thiazinecarboxamide
4-bromo-N-[(E)-[(E)-3-phenylprop-2-enylidene]amino]benzenesulfonamide
[5-(7-Hydroxy-4-oxochromen-2-yl)-2-methoxyphenyl] hydrogen sulate
C16H12O8S (364.02528720000004)
5-xanthylic acid
A purine ribonucleoside 5-monophosphate having xanthine as the nucleobase. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)
Dianion of 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.
NS 1738
C14H9Cl2F3N2O2 (363.99931499999997)
NS 1738 (NSC 213859) is a novel positive allosteric modulator of the α7 nAChR, with respect to positive modulation of α7 nAChR (EC50=3.4 μM in oocyte experiments).
VPC-70619
C16H8ClF3N4O (364.03387039999996)
VPC-70619 is a potent, orally active N-Myc inhibitor. VPC-70619 blocks the N-Myc-Max heterocomplex from binding to DNA E-boxes and demonstrated strong inhibition activity against N-Myc-dependent cell lines as well as high bioavailability in both oral and intraperitoneal administration[1].
(8-hydroxy-6-methoxy-3-methyl-9,10-dioxoanthracen-2-yl)oxidanesulfonic acid
C16H12O8S (364.02528720000004)
1-{6-bromo-9h-pyrido[3,4-b]indol-1-yl}-2-phenylethanone
n-[(4r)-4-(5-bromo-1-methoxyindol-3-yl)-3,4,5,6-tetrahydropyrimidin-2-yl]ethanimidic acid
C15H17BrN4O2 (364.05348019999997)
methyl 1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracene-9-carboxylate
methyl 2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1h-2-benzofuran-5-yl)benzoate
1-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}-2-phenylethanone
(5r)-5-[(6-bromo-1h-indol-3-yl)methyl]-2-imino-5-methoxy-1,3-dimethylimidazolidin-4-one
C15H17BrN4O2 (364.05348019999997)
5,7,11,19-tetraoxapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13,15,17-hexaen-16-yloxidanesulfonic acid
C16H12O8S (364.02528720000004)
n-[4-(5-bromo-1-methoxyindol-3-yl)-3,4,5,6-tetrahydropyrimidin-2-yl]ethanimidic acid
C15H17BrN4O2 (364.05348019999997)
(1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl)acetic acid
[(9s)-1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl]acetic acid
n-[(1r,2r)-3-(acetyloxy)-1-hydroxy-1-(4-nitrophenyl)propan-2-yl]-2,2-dichloroethanimidic acid
n-{4-hydroxy-5-[(5-methylfuran-2-yl)methyl]-5h-1,3-thiazol-2-ylidene}-4-methylbenzenesulfonamide
[(2s,3s,4s,5s)-5-(2,6-dihydroxypurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid
5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochromene-6-sulfonic acid
C16H12O8S (364.02528720000004)
4-chloro-2,8-dihydroxy-6-(methoxycarbonyl)-9-oxoxanthene-1-carboxylic acid
(1r,12r)-5,7,11,19-tetraoxapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13,15,17-hexaen-16-yloxidanesulfonic acid
C16H12O8S (364.02528720000004)